About 100 reports

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Colorectal Cancer in 18 Major Markets Colorectal Cancer (CRC) affects the colon and rectum, which are a part of the large intestine. Colorectal cancer occurs when tumours, identified as polyps, develop in the lining of the large intestine. Some of these polyps can become...

  • Colorectal Cancer
  • United States
  • China
  • Italy
  • Brazil
  • India
  • Australia
  • United Kingdom
  • Canada
  • France
  • Japan
  • Germany
  • Turkey
  • Mexico
  • Spain
  • Russia
  • Argentina
  • South Africa
  • Saudi Arabia
  • Cancer Incidence
  • Hospital Admission

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2025 Summary Colorectal cancer (CRC) is a cancer that starts in the colon or the rectum (ACS, 2016). CRC is one of the most common types of cancers diagnosed; it is the third most common cancer among men and the second most common in women, worldwide (Ferlay...

  • Colorectal Cancer
  • World
  • Cancer Incidence
  • Smoking Prevalence

Metastatic Colorectal Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic Colorectal Cancer (Oncology) pipeline landscape. Metastatic colorectal...

  • Colorectal Cancer
  • World

Some of the major factors driving units down are an unfavorable reimbursement structure and strong lobbying against using colonography as one of the key colon cancer screening methods. Most of sales have occurred in the period of 2004 and 2009 when colongraphy was gaining traction. However, since 2009 the market started to rapidly decline....

  • Colorectal Cancer
  • United States
  • Colorectal Cancer Screening Coverage

The U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, endoscopic retrograde cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus....

  • Endoscopic Device
  • Endoscope
  • Colorectal Cancer
  • Hospital
  • United States
  • Colorectal Cancer Screening Coverage

Critical Outcome Technologies Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Critical Outcome Technologies Inc. - Product Pipeline Review - 2016’, provides an overview of the Critical Outcome Technologies Inc.’s pharmaceutical research and development focus. The report provides comprehensive...

  • Colorectal Cancer
  • World

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected to experience a moderate growth between 2015 and 2025. The main drivers of growth will be the expected increased...

  • Colorectal Cancer
  • World
  • United States
  • China
  • Japan
  • Colorectal Cancer Screening Coverage
  • Cancer Incidence

Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose]...

  • Oncology
  • Colorectal Cancer
  • Infectious Disease
  • Breast Cancer
  • World

Summary DanDrit Biotech A/S (DanDrit Biotech), a subsidiary of DanDrit Biotech USA Inc is a biotechnology company that provides clinical development solutions. The company offers polyvalent vaccine products. Its products are used in broad spectrum of cancer and testis antigens and have low levels of expression of the melanocyte...

  • Pharmaceutical
  • Clinical Trial
  • Vaccine
  • Biotechnology
  • Cell Therapy
  • Colorectal Cancer
  • Denmark
  • APAC
  • Europe
  • North America
  • Singapore
  • Middle East
  • Africa

Serine/Threonine-Protein Kinase A-Raf (A-Raf Kinase or Proto-Oncogene A-Raf or Proto-Oncogene Pks or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Serine/Threonine-Protein Kinase A-Raf (A-Raf Kinase or Proto-Oncogene A-Raf or Proto-Oncogene Pks or EC 2.7.11.1) - Pipeline Review, H1 2016’,...

  • Oncology
  • Colorectal Cancer
  • Pharmaceutical
  • World

Metastatic Colorectal Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Colorectal Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Colorectal Cancer
  • World

Global carcinoembryonic antigen market is expected to reach USD 2.56 Billion by 2022. Constant technological advancements pertaining to the development of novel biomarkers which can be used in combination with other biomarkers is expected to boost usage rates over the forecast period. Furthermore, the increasing prevalence of cancer is expected...

  • Healthcare
  • Colorectal Cancer
  • Diagnostics
  • Hormone
  • World
  • Cancer Incidence
  • Cause-Specific Mortality Rate

Summary Aposense Ltd. (Aposense), formerly NeuroSurvival Technologies Ltd, is a biotechnology products that offers pharmaceutical products. The company provides formulation of proprietary conjugates to known approved therapies to improve their efficacy. Its pipeline products include ATT-11T, ATT-GEM and ATT-LD. Aposense’s ATT-Gem...

  • Pharmaceutical
  • Biotechnology
  • Medical Equipment
  • Healthcare
  • Targeted Therapy
  • Lung Cancer
  • Psychotic Disorder
  • Ovarian Cancer
  • Colorectal Cancer
  • Pancreatic Cancer
  • APAC
  • Middle East
  • Europe
  • North America
  • Africa
  • Israel

Disease Overview Colorectal cancer (CRC) is one of the "big four" tumor types, the third most common cancer to affect both men and women, and the third-leading cause of cancer-related death. The main differentiator between colon cancer and rectal cancer is the location of the primary tumor, but identical etiology and similar...

  • Colorectal Cancer

Colorectal cancer

4385 5000 3900

Pipeline candidates for the colorectal cancer market will pursue novel mechanisms of action to distinguish themselves in an increasingly crowded market. This report addresses the following questions: - How are new therapies differentiating themselves in the increasingly crowded and price-sensitive CRC market? - How...

  • Colorectal Cancer
  • United States
  • Japan
  • European Union
  • Cancer Incidence
  • Colorectal Cancer Screening Coverage

Summary Miraculins Inc. (Miraculins) is a biotechnology company that offers therapeutic products. The company acquires, develops and commercializes risk assessment tests, and non invasive diagnostic tests for the healthcare market. It provides discovery and validation of cancer biomarkers for development of diagnostic tools and...

  • Diagnostics
  • Clinical Trial
  • Gastric Cancer
  • Pancreatic Cancer
  • Colorectal Cancer
  • Canada
  • United States
  • China
  • Prescriptions Filled
  • In Store Traffic

About colorectal cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Some of...

  • Colorectal Cancer
  • Chemotherapy
  • Oncology
  • Japan
  • APAC
  • China
  • Southeast Asia
  • Mortality Rate
  • Biologics Penetration Rate

Product and Pipeline Analysis of the Global Colorectal Cancer Market : Targeted Therapeutics and Immunology Combine to Take Colorectal Cancer Treatments to the Next Level Research Overview This Frost & Sullivan research service on the global colorectal cancer market provides in-depth analyses of industry trends, market...

  • Colorectal Cancer
  • World

About Colorectal Cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal...

  • Colorectal Cancer
  • World
  • Biologics Penetration Rate
  • Cancer Survival Rate

Two recent developments appear poised to shift the typical US-based treatment regimen for first-line metastatic colorectal cancer in patients with wild-type KRAS gene mutations: approval of Amgen's Vectibix in this setting and study data presented at the ASCO annual meeting from the CALGB80405...

  • Colorectal Cancer
  • United States
  • World